Want to see AU:AEV full AI Analyst Report?
Top Page
Avenira Limited
(Sydney:AEV)
Select Model
Select Model
Rating:43Neutral
Price Target:
AU$0.01
â–²(25.00% Upside)
Action:Reiterated
Date:10/03/26
The score is primarily driven by very weak financial performance—near-zero revenue, persistent losses, and ongoing cash burn—partly offset by a comparatively healthier balance sheet with moderate leverage. Limited technical data restricts confidence in momentum/trend signals, while valuation is constrained by negative earnings and no dividend support.
Positive Factors
Growing Equity Base
The substantial increase in reported equity provides a stronger capital base than the company had several years ago. This can improve resilience while projects are developed, although continued losses could gradually erode that support if operating performance does not improve.
Negative Factors
Minimal Revenue Generation
Near-zero revenue indicates that the company has not yet established a meaningful operating base or demonstrated commercial scale. Without a material and sustained sales ramp, development activities are unlikely to translate into self-funded operations or durable earnings.
Read all positive and negative factors
Positive Factors
Negative Factors
Growing Equity Base
The substantial increase in reported equity provides a stronger capital base than the company had several years ago. This can improve resilience while projects are developed, although continued losses could gradually erode that support if operating performance does not improve.
Read all positive factors
Avenira Limited (AEV) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$95.03M
Dividend YieldN/A
Average Volume (3M)648.30K
Price to Earnings (P/E)―
Beta (1Y)0.48
Revenue GrowthN/A
EPS Growth50.00%
CountryAU
Employees2
SectorBasic Materials
Sector Strength58
IndustryIndustrial Materials
Share Statistics
EPS (TTM)<0.01
Shares Outstanding13,575,225,000
10 Day Avg. Volume648,296
30 Day Avg. Volume648,296
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)1.41
Price to Sales (P/S)0.00
P/FCF Ratio-7.93
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Avenira Limited Business Overview & Revenue Model
Company Description
Avenira Limited, along with its subsidiaries, is actively involved in the exploration and development of mineral deposits throughout Australia. The company's primary focus is on identifying gold and phosphate reserves. Its principal asset is the w...
Avenira Limited Financial Statement Overview
Summary
Income Statement
8
Very Negative
Balance Sheet
54
Neutral
Cash Flow
14
Very Negative
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 5.79K | 3.15K |
| Gross Profit | -25.47K | -14.03K | -14.73K | -12.39K | -31.34K |
| EBITDA | -3.20M | -4.12M | -2.91M | -3.18M | -2.84M |
| Net Income | -3.34M | -4.99M | -3.12M | -3.20M | -2.88M |
Balance Sheet | |||||
| Total Assets | 26.81M | 20.40M | 21.89M | 17.36M | 12.41M |
| Cash, Cash Equivalents and Short-Term Investments | 759.41K | 517.61K | 425.96K | 3.27M | 1.01M |
| Total Debt | 4.09M | 2.07M | 0.00 | 3.46M | 3.22M |
| Total Liabilities | 7.37M | 5.47M | 6.08M | 6.50M | 6.07M |
| Stockholders Equity | 19.44M | 14.93M | 15.81M | 10.86M | 6.34M |
Cash Flow | |||||
| Free Cash Flow | -3.45M | -6.42M | -5.50M | -4.72M | -3.31M |
| Operating Cash Flow | -3.34M | -2.73M | -1.20M | -1.78M | -1.60M |
| Investing Cash Flow | -5.96M | -3.61M | -3.82M | -2.95M | -2.70M |
| Financing Cash Flow | 9.54M | 6.43M | 2.18M | 6.98M | 2.18M |
Avenira Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
48 Neutral | AU$25.69M | -4.59 | -19.95% | ― | ― | -2.96% | |
47 Neutral | AU$18.01M | -4.96 | -10.76% | ― | ― | 49.10% | |
45 Neutral | AU$24.79M | -1.26 | -29.51% | ― | -100.00% | -164.77% | |
43 Neutral | AU$95.03M | -9.78 | -16.67% | ― | ― | 50.00% | |
42 Neutral | AU$13.38M | -2.89 | -83.24% | ― | ― | -9.30% | |
38 Underperform | AU$28.90M | -10.00 | -4.04% | ― | ― | ― |
* Basic Materials Sector Average
AU:AEV
Avenira Limited
―
―
―
AU:REE
RareX Limited
0.01
-0.02
-65.63%
AU:VML
Vital Metals Ltd
0.09
-0.11
-53.00%
AU:AR3
Australian Rare Earths Limited
0.10
-0.02
-20.00%
AU:PL9
Arizona Lithium Limited
0.01
0.00
0.00%
AU:SGA
Sarytogan Graphite Limited
0.07
-0.03
-30.61%
Avenira Limited Corporate Events
Avenira files 2026 corporate governance statement and Appendix 4G
Sep 29, 2026
Avenira Limited has lodged its annual corporate governance statement for the year ended 30 June 2026, confirming board approval and hosting the document on its governance webpage. The filing is accompanied by a completed Appendix 4G, which acts as...
Avenira Publishes 2026 Annual Report Overview
Sep 29, 2026
Avenira Limited is an Australian-listed company whose latest communication is its annual report for the 2026 financial year. The report package reflects standard corporate disclosure practices, including audited financial statements, governance co...
Avenira Extends Closing Date for Renounceable Rights Issue
Sep 20, 2026
Avenira Limited has lodged an updated Appendix 3B with the ASX for a proposed renounceable pro rata issue of securities. The update relates to an existing capital-raising proposal that is being conducted under ASX listing rules and is intended to ...
Avenira Extends Rights Issue to Court Cornerstone Investors
Sep 20, 2026
Avenira Limited has updated shareholders on its pro rata renounceable rights issue, which offers three new shares for every two held and aims to raise up to about $48.9 million before costs. Major shareholder Hebang Biotechnology has committed to ...
Avenira Locks In Hebang Offtake Deal for Wonarah Phosphate
Sep 15, 2026
Avenira has signed a four-year offtake and distribution agreement with Hebang Biotechnology for 500,000 tonnes per annum of phosphate rock from its Wonarah project, securing a sales pathway for more than 80% of the expected annual DSO production. ...
Avenira Launches Major Drilling Campaign at Jundee South Gold Project
Sep 14, 2026
Avenira Limited has commenced an 11,590-metre air core drilling campaign at its Jundee South Gold Project in Western Australia, signalling a significant push to advance exploration in the area. The program targets multiple tenements using geologic...
Avenira Extends Closing Date for Renounceable Rights Issue
Sep 13, 2026
Avenira Limited has updated its proposed renounceable pro rata issue of securities, lodged via an Appendix 3B filing with the ASX. The update confirms that the offer remains a rights-style capital raising directed at existing shareholders, with th...
Avenira Extends Closing Date for Renounceable Pro Rata Offer
Sep 7, 2026
Avenira Limited has updated its proposed renounceable pro rata issue of securities, lodging an amended Appendix 3B with the ASX on 7 September 2026. The key change is an extension of the offer’s closing date from the schedule outlined in its...
Avenira launches $49m rights issue to fund Wonarah mine transition
Aug 31, 2026
Avenira Limited has launched a three-for-two renounceable rights issue to raise up to $49 million, with a prospectus lodged with ASIC in mid-August 2026. The capital raising is intended to fund the transition of its Wonarah project from a permitte...
Avenira launches renounceable rights issue to fund Wonarah phosphate development
Aug 24, 2026
Avenira Limited has launched a pro-rata renounceable rights issue, offering eligible shareholders three new shares for every two held at an issue price of $0.006, to raise up to about $48.9 million before costs. The offer is tradeable on ASX and i...
Avenira launches $48.9m rights issue to fund Wonarah phosphate growth
Aug 24, 2026
Avenira Limited has opened a pro-rata renounceable rights issue, offering eligible shareholders three new shares for every two held at an issue price of $0.006 per share, to raise up to about $48.9 million before costs. The prospectus has been dis...
Avenira starts trading renounceable rights to fund Wonarah phosphate push
Aug 18, 2026
Avenira Limited has commenced trading of rights under its renounceable entitlement issue on the ASX, listed as AEVR, following the announcement earlier in the week. Rights trading is scheduled to run until 3 September 2026, giving investors a defi...
Avenira launches $48.9m renounceable entitlement offer
Aug 17, 2026
Avenira Limited has launched a renounceable pro-rata entitlement offer to raise up to approximately $48.9 million before costs, issuing up to 8.15 billion new shares at $0.006 each on the basis of three new shares for every two held. Eligible shar...
Avenira launches $49m rights issue to fund Wonarah phosphate project
Aug 17, 2026
Avenira Limited has launched a three-for-two renounceable rights issue priced at 0.6 cents per share to raise up to approximately $49 million, a discount to its recent trading levels, with rights trading commencing on 19 August 2026 and the offer ...
Avenira shifts financial year-end to align with major shareholder
Aug 10, 2026
Avenira Limited has resolved to change its financial year-end from 30 June to 31 December to align with the financial calendar of its major shareholder, Sichuan Hebang Biotechnology Corporation. The board says the move, made under Australian corpo...
Avenira Resets Wonarah Phosphate Timeline as Key Infrastructure and Funding Advance
Jul 29, 2026
Avenira’s June quarter activities show the Wonarah Phosphate Project advancing with key team appointments, infrastructure tenders, and heritage processes underway, alongside strengthened funding after a Hebang placement and repayment of a pr...
Avenira Confirms Compliance on Large ASX Share Issuance
Jul 3, 2026
Avenira Limited has advised that it has issued 1,171,445,635 fully paid ordinary shares, which have been quoted on the ASX without a prospectus under the disclosure exemptions of the Corporations Act. The company confirmed it is up to date with it...
Avenira Seeks ASX Quotation for 1.17 Billion New Shares
Jul 3, 2026
Avenira Limited, an Australia-based company listed on the ASX as AEV, participates in Australia’s public equity markets by issuing ordinary fully paid shares. Its listing status enables investors to trade its securities and offers the compan...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.